SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics™, a privately held, venture-backed company today announced the appointment of Sidney Stolz as Chief Growth Officer. In this position, Sid will focus on the strategic expansion of Pathway’s direct-to-consumer genetic testing services.
